Searched for
INDIAN DIALYSIS MARKET
Lord's Mark Industries Ltd. announces AI-supported Dialysis ecosystem launchLord's Mark Industries Ltd. has launched an integrated dialysis ecosystem in Ahmedabad, featuring the AI-driven Renalyx Machine. This CE-ce...
Wealth creation is also about ignoring noise on the street: 15 mid- and small-cap stocks from different sectors which fit the billIn the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...
Home nursing, oxygen, physio - health insurance covers only 60–180 days after hospitalisation; here’s how to plan the restHome nursing, physiotherapy, oxygen support—health insurance can cover these for 60-180 days after discharge, with conditions. The rest of ...
Lords Mark Industries Ltd.–Renalyx approved to manufacture Class C AI-based haemodialysis machines; earns global CE markingLords Mark Industries Ltd. has achieved a significant feat by securing a CDSCO license to produce Class C AI-based smart haemodialysis mach...
Nephrocare Health IPO Day 3: GMP slips to 2% and subscription remains subdued — Should you apply?Nephrocare Health IPO: The stock’s grey-market premium has slipped to 1.7% from 4.35%, indicating softer sentiment and a likely listing ran...
Nephrocare Health IPO Day 2: GMP improves but subscription demand remains weak. Should you apply?Nephrocare Health Services’ Rs 871-crore IPO has seen a muted initial response despite an improving grey market premium. Strong financial g...
Nephrocare Health IPO Day 1: Issue subscribed 7%; no GMP. Should investors apply?Nephrocare Health IPO consists of a ₹353-crore fresh issue and a ₹518-crore offer for sale. Of the fresh issue funds, Nephrocare Health Ser...
Nephrocare Health IPO: Check GMP, review, subscription and other detailsNephrocare Health Services, India's largest dialysis provider, launched its Rs 871 crore IPO on Wednesday, offering a stake in its rapidly ...
NephroPlus announces IPO launch on December 10. Check key detailsNephrocare Health Services’ IPO opens December 10 with a fresh issue and OFS totaling significant funds. Proceeds will support new dialysis...
Lord’s Mark Industries acquires 85% stake in Renalyx to scale indigenous dialysis technologyLord's Mark Industries has acquired an 85% stake in Renalyx Health Systems, a Bengaluru-based med-tech firm known for its AI-powered smart ...
Dialysis chain NephroPlus eyes Rs 2,000 crore IPONephrocare Health Services, known as NephroPlus, is set to file its DRHP with SEBI by the end of this month, aiming to raise over ₹2,000 cr...
Quadria Capital picks up stake in NephroPlus for $102 mlnQuadria Capital invests $102 million in NephroPlus, India's largest dialysis chain, acquiring a minority stake. The move supports NephroPlu...
Nephrocare India plans to set up 22 kidney care centres across India by March 2026Nephrocare India plans to establish 22 kidney care centres across India by March 2026 to expand its presence. The company is exploring opti...
NephroPlus to open up to 55 dialysis centres by 2018-endWhen asked about investments, he said NephroPlus would be investing around Rs 1 crore per centre, which would have around 10-12 dialysis ma...
Tata Capital sells stake in Indian dialysis service provider to Fresenius Medical CareFMC’s acquisition of Sandor marks the beginning of a series of investments the company intends for its expansion in the Indian dialysis mar...
Health startups offer low-cost treatment and link patients with local doctorsRecent changes in the Drug Price Control Act, which reduced the operational margins for pharmacies and other retailers from 20% to about 14...
NephroPlus: A startup betting big on walk-in dialysis careWith a global recession underway, the timing for launching a startup might have seemed inopportune, but Vikram Vuppala and his fellow found...
NephroPlus: A startup betting big on walk-in dialysis careWith a global recession underway, the timing for launching a startup might have seemed inopportune, but Vikram Vuppala and his fellow found...
- US-based DaVita picks up stake in NephroLife Care for India entry
US-based kidney care services provider DaVita has picked up a significant stake in Bangalore-based renal care services provider NephroLife ...
- Baxter seeks shot in the arm, eyes acquisitions
Critical therapy giant, Baxter is scouting for companies in India for a possible acquisition soon.